RESUMEN
The outer mitochondrial membrane (OMM) is essential for cellular homeostasis. Yet little is known of the mechanisms that remodel it during natural stresses. We found that large "SPOTs" (structures positive for OMM) emerge during Toxoplasma gondii infection in mammalian cells. SPOTs mediated the depletion of the OMM proteins mitofusin 1 and 2, which restrict parasite growth. The formation of SPOTs depended on the parasite effector TgMAF1 and the host mitochondrial import receptor TOM70, which is required for optimal parasite proliferation. TOM70 enabled TgMAF1 to interact with the host OMM translocase SAM50. The ablation of SAM50 or the overexpression of an OMM-targeted protein promoted OMM remodeling independently of infection. Thus, Toxoplasma hijacks the formation of SPOTs, a cellular response to OMM stress, to promote its growth.
Asunto(s)
Membranas Mitocondriales/fisiología , Proteínas del Complejo de Importación de Proteínas Precursoras Mitocondriales/metabolismo , Proteínas Protozoarias/metabolismo , Toxoplasma/fisiología , Animales , Línea Celular , GTP Fosfohidrolasas/metabolismo , Humanos , Membranas Intracelulares/fisiología , Membranas Intracelulares/ultraestructura , Ratones , Proteínas de Transporte de Membrana Mitocondrial/metabolismo , Membranas Mitocondriales/ultraestructura , Proteínas Mitocondriales/metabolismo , Unión Proteica , Estrés Fisiológico , Toxoplasma/crecimiento & desarrollo , Toxoplasma/ultraestructura , Toxoplasmosis/parasitología , Vacuolas/fisiología , Vacuolas/ultraestructuraRESUMEN
Drug repurposing is an attractive option for identifying new treatment strategies, in particular in extraordinary situations of urgent need such as the current coronavirus disease 2019 (Covid-19) pandemic. Recently, the World Health Organization announced testing of three drugs as potential Covid-19 therapeutics that are known for their dampening effect on the immune system. Thus, the underlying concept of selecting these drugs is to temper the potentially life-threatening overshooting of the immune system reacting to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. This viewpoint discusses the possibility that the impact of these and other drugs on autophagy contributes to their therapeutic effect by hampering the SARS-CoV-2 life cycle.
Asunto(s)
Antivirales/farmacología , Artesunato/farmacología , Autofagia/efectos de los fármacos , Tratamiento Farmacológico de COVID-19 , Reposicionamiento de Medicamentos , Mesilato de Imatinib/farmacología , Infliximab/farmacología , Pandemias , SARS-CoV-2/efectos de los fármacos , Antidepresivos/farmacología , Antivirales/uso terapéutico , Artesunato/uso terapéutico , Cloroquina/farmacología , Desarrollo de Medicamentos , Retículo Endoplásmico/efectos de los fármacos , Retículo Endoplásmico/fisiología , Retículo Endoplásmico/virología , Endosomas/efectos de los fármacos , Endosomas/virología , Humanos , Hidroxicloroquina/farmacología , Mesilato de Imatinib/uso terapéutico , Infliximab/uso terapéutico , Membranas Intracelulares/efectos de los fármacos , Membranas Intracelulares/fisiología , Membranas Intracelulares/virología , Ivermectina/farmacología , Macrólidos/farmacología , Coronavirus del Síndrome Respiratorio de Oriente Medio/efectos de los fármacos , Niclosamida/farmacología , Niclosamida/uso terapéutico , ARN Viral/metabolismo , SARS-CoV-2/fisiología , Replicación ViralRESUMEN
As an important form of selective autophagy in cells, ER-phagy (endoplasmic reticulum-selective autophagy), the autophagic degradation of endoplasmic reticulum (ER), degrades ER membranes and proteins to maintain cellular homeostasis. The relationship between ER-phagy and human diseases, including neurodegenerative disorders, cancer, and other metabolic diseases has been unveiled by extensive research in recent years. Starting with the catabolic process of ER-phagy and key mediators in this pathway, this paper reviews the advances in the mechanism of ER-phagy and its diseases relevance. We hope to provide some enlightenment for further study on ER-phagy and the development of novel therapeutic strategies for related diseases.
Asunto(s)
Retículo Endoplásmico/patología , Animales , Autofagia/fisiología , Estrés del Retículo Endoplásmico/fisiología , Homeostasis/fisiología , Humanos , Membranas Intracelulares/fisiologíaRESUMEN
The endoplasmic reticulum (ER) is an organelle with remarkable plasticity, capable of rapidly changing its structure to accommodate different functions based on intra- and extracellular cues. One of the ER structures observed in plants is known as "organized smooth endoplasmic reticulum" (OSER), consisting of symmetrically stacked ER membrane arrays. In plants, these structures were first described in certain specialized tissues, e.g. the sieve elements of the phloem, and more recently in transgenic plants overexpressing ER membrane resident proteins. To date, much of the investigation of OSER focused on yeast and animal cells but research into plant OSER has started to grow. In this update, we give a succinct overview of research into the OSER phenomenon in plant cells with case studies highlighting both native and synthetic occurrences of OSER. We also assess the primary driving forces that trigger the formation of OSER, collating evidence from the literature to compare two competing theories for the origin of OSER: that OSER formation is initiated by oligomerizing protein accumulation in the ER membrane or that OSER is the result of ER membrane proliferation. This has long been a source of controversy in the field and here we suggest a way to integrate arguments from both sides into a single unifying theory. Finally, we discuss the potential biotechnological uses of OSER as a tool for the nascent plant synthetic biology field with possible applications as a synthetic microdomain for metabolic engineering and as an extensive membrane surface for synthetic chemistry or protein accumulation.
Asunto(s)
Vías Biosintéticas , Retículo Endoplásmico Liso/fisiología , Retículo Endoplásmico Liso/ultraestructura , Membranas Intracelulares/fisiología , Membranas Intracelulares/ultraestructura , Células Vegetales/fisiología , Células Vegetales/ultraestructuraRESUMEN
Lysosomal membrane permeabilization (LMP) has been proposed to precede nanoparticle-induced macrophage injury and NLRP3 inflammasome activation; however, the underlying mechanism(s) of LMP is unknown. We propose that nanoparticle-induced lysosomal hyperpolarization triggers LMP. In this study, a rapid non-invasive method was used to measure changes in lysosomal membrane potential of murine alveolar macrophages (AM) in response to a series of nanoparticles (ZnO, TiO2, and CeO2). Crystalline SiO2 (micron-sized) was used as a positive control. Changes in cytosolic potassium were measured using Asante potassium green 2. The results demonstrated that ZnO or SiO2 hyperpolarized the lysosomal membrane and decreased cytosolic potassium, suggesting increased lysosome permeability to potassium. Time-course experiments revealed that lysosomal hyperpolarization was an early event leading to LMP, NLRP3 activation, and cell death. In contrast, TiO2- or valinomycin-treated AM did not cause LMP unless high doses led to lysosomal hyperpolarization. Neither lysosomal hyperpolarization nor LMP was observed in CeO2-treated AM. These results suggested that a threshold of lysosomal membrane potential must be exceeded to cause LMP. Furthermore, inhibition of lysosomal hyperpolarization with Bafilomycin A1 blocked LMP and NLRP3 activation, suggesting a causal relation between lysosomal hyperpolarization and LMP.
Asunto(s)
Membranas Intracelulares/fisiología , Lisosomas/metabolismo , Potenciales de la Membrana/fisiología , Nanopartículas/toxicidad , Animales , Muerte Celular/efectos de los fármacos , Citosol/metabolismo , Femenino , Concentración de Iones de Hidrógeno , Inflamasomas/metabolismo , Membranas Intracelulares/efectos de los fármacos , Lisosomas/efectos de los fármacos , Macrófagos Alveolares/efectos de los fármacos , Macrófagos Alveolares/metabolismo , Masculino , Potenciales de la Membrana/efectos de los fármacos , Ratones Endogámicos C57BL , Modelos Biológicos , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Permeabilidad , Potasio/metabolismo , Reproducibilidad de los Resultados , Dióxido de Silicio/toxicidadRESUMEN
Myocardial function is tuned by dynamic changes in length and load via mechano-calcium feedback. This regulation may be significantly affected by heart rhythm. We evaluated the mechano-induced modulation of contractility and Ca-transient (CaT) in the rat myocardium subjected to twitch-by-twitch shortening-re-lengthening (↓-↑) trains of different lengths (N = 1 720 cycles) at low (1 Hz) and near-physiological (3.5 Hz) pacing rates. Force/CaT characteristics were evaluated in the first post-train isometric twitch (immediate effect) and during slow changes (delayed maximal elevation/decrease) and compared with those of the pre-train twitch. The immediate inotropic effect was positive for N = 30 720 and negative for N = 1 20, while the delayed effect was always positive. The immediate and delayed inotropic effects were significantly higher at 3.5-Hz vs 1-Hz (P < 0.05). The prominent inotropism was accompanied by much smaller changes in the CaT diastolic level/amplitude. The shortening-re-lengthening train induced oscillations of the slow change in force at 3.5-Hz (always) and at 1-Hz (â¼50% of muscles), which were dependent of the train length and independent of the pacing rate. We suggest that twitch-by-twitch shortening-re-lengthening of cardiac muscle decreases Ca2+ buffering by troponin C and elevates Ca2+ loading of the sarcoplasmic reticulum (SR); the latter cumulatively depends on the train length. A high pacing rate intensifies the cumulative transient shift in the SR Ca2+ loading, augmenting the post-train inotropic response and prolonging its recovery to the pre-train level. The pacing-dependent mechano-induced inotropic effects remain to be elucidated in the myocardium with impaired Ca handling.
Asunto(s)
Fenómenos Biomecánicos/fisiología , Calcio/metabolismo , Miocardio/metabolismo , Animales , Diástole/fisiología , Frecuencia Cardíaca/fisiología , Membranas Intracelulares/fisiología , Contracción Miocárdica/fisiología , Ratas , Ratas Wistar , Retículo Sarcoplasmático/fisiología , Factores de TiempoRESUMEN
As part of the lysosomal degradation pathway, the endosomal sorting complexes required for transport (ESCRT-0 to -III/VPS4) sequester receptors at the endosome and simultaneously deform the membrane to generate intraluminal vesicles (ILVs). Whereas ESCRT-III/VPS4 have an established function in ILV formation, the role of upstream ESCRTs (0 to II) in membrane shape remodeling is not understood. Combining experimental measurements and electron microscopy analysis of ESCRT-III-depleted cells with a mathematical model, we show that upstream ESCRT-induced alteration of the Gaussian bending rigidity and their crowding in concert with the transmembrane cargo on the membrane induce membrane deformation and facilitate ILV formation: Upstream ESCRT-driven budding does not require ATP consumption as only a small energy barrier needs to be overcome. Our model predicts that ESCRTs do not become part of the ILV, but localize with a high density at the membrane neck, where the steep decline in the Gaussian curvature likely triggers ESCRT-III/VPS4 assembly to enable neck constriction and scission.
Asunto(s)
Complejos de Clasificación Endosomal Requeridos para el Transporte/metabolismo , Endosomas/metabolismo , Membranas Intracelulares/fisiología , Modelos Biológicos , Endosomas/ultraestructura , Células HeLa , HumanosRESUMEN
Given the speed of viral infection spread, repurposing of existing drugs has been given the highest priority in combating the ongoing COVID-19 pandemic. Only drugs that are already registered or close to registration, and therefore have passed lengthy safety assessments, have a chance to be tested in clinical trials and reach patients quickly enough to help in the current disease outbreak. Here, we have reviewed available evidence and possible ways forward to identify already existing pharmaceuticals displaying modest broad-spectrum antiviral activity which is likely linked to their high accumulation in cells. Several well studied examples indicate that these drugs accumulate in lysosomes, endosomes and biological membranes in general, and thereby interfere with endosomal pathway and intracellular membrane trafficking crucial for viral infection. With the aim to identify other lysosomotropic drugs with possible inherent antiviral activity, we have applied a set of clear physicochemical, pharmacokinetic and molecular criteria on 530 existing drugs. In addition to publicly available data, we have also used our in silico model for the prediction of accumulation in lysosomes and endosomes. By this approach we have identified 36 compounds with possible antiviral effects, also against coronaviruses. For 14 of them evidence of broad-spectrum antiviral activity has already been reported, adding support to the value of this approach. Presented pros and cons, knowledge gaps and methods to identify lysosomotropic antivirals, can help in the evaluation of many drugs currently in clinical trials considered for repurposing to target COVID-19, as well as open doors to finding more potent and safer alternatives.
Asunto(s)
Antivirales/uso terapéutico , Betacoronavirus , Infecciones por Coronavirus/tratamiento farmacológico , Reposicionamiento de Medicamentos , Lisosomas/efectos de los fármacos , Pandemias , Neumonía Viral/tratamiento farmacológico , Antiinflamatorios/farmacocinética , Antivirales/efectos adversos , Antivirales/farmacocinética , Arritmias Cardíacas/inducido químicamente , Azitromicina/farmacocinética , Azitromicina/uso terapéutico , COVID-19 , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Cloroquina/farmacocinética , Cloroquina/uso terapéutico , Simulación por Computador , Evaluación Preclínica de Medicamentos , Endosomas/efectos de los fármacos , Humanos , Concentración de Iones de Hidrógeno , Hidroxicloroquina/farmacocinética , Hidroxicloroquina/uso terapéutico , Membranas Intracelulares/fisiología , Lisosomas/química , Lípidos de la Membrana/metabolismo , Modelos Biológicos , Fosfolípidos/metabolismo , SARS-CoV-2 , Tensoactivos/farmacocinética , Internalización del Virus , Tratamiento Farmacológico de COVID-19RESUMEN
Both inflammasomes and autophagy have important roles in the intracellular homeostasis, inflammation, and pathology; the dysregulation of these processes is often associated with the pathogenesis of numerous cancers. In addition, they can crosstalk with each other in multifaceted ways to influence various physiological and pathological responses, including cancer. Multiple molecular mechanisms connect the autophagy pathway to inflammasome activation and, through this, may influence the outcome of pro-tumor or anti-tumor responses depending on the cancer types, microenvironment, and the disease stage. In this review, we highlight the rapidly growing literature on the various mechanisms by which autophagy interacts with the inflammasome pathway, to encourage additional applications in the context of tumors. In addition, we provide insight into the mechanisms by which pathogen modulates the autophagy-inflammasome pathway to favor the infection-induced carcinogenesis. We also explore the challenges and opportunities of using multiple small molecules/agents to target the autophagy/inflammasome axis and their effects upon cancer treatment. Finally, we discuss the emerging clinical efforts assessing the potential usefulness of targeting approaches for either autophagy or inflammasome as anti-cancer strategies, although it remains underexplored in terms of their crosstalks.
Asunto(s)
Autofagia/fisiología , Inflamasomas/fisiología , Neoplasias/inmunología , Animales , Autofagia/efectos de los fármacos , Ensayos Clínicos como Asunto , Homeostasis , Humanos , Inflamasomas/efectos de los fármacos , Membranas Intracelulares/fisiología , Mitocondrias/metabolismo , Mitofagia/efectos de los fármacos , Mitofagia/fisiología , Modelos Biológicos , Proteína con Dominio Pirina 3 de la Familia NLR/fisiología , Proteínas de Neoplasias/fisiología , Neoplasias/fisiopatología , ARN Bicatenario/fisiología , ARN Neoplásico/fisiología , Especies Reactivas de Oxígeno/metabolismoRESUMEN
Lysosomes are central organelles for cellular degradation and energy homeostasis. In addition, lysosomal membrane permeabilization (LMP) and subsequent release of lysosomal content to the cytosol can initiate programmed cell death. The extent of LMP and available repair mechanisms determine the cell fate after lysosomal damage. In this study, we aimed to investigate the premises for lysosomal membrane repair after LMP and found that lysosomal membrane damage initiated by L-leucyl-L-leucine methyl ester (LLOMe) caused caspase-dependent apoptosis in almost 50% of the cells, while the rest recovered. Immediately after LLOMe addition, lysosomal proteases were detected in the cytosol and the ESCRT-components ALIX and CHMP4B were recruited to the lysosomal membrane. Next, lysophagic clearance of damaged lysosomes was evident and a concentration-dependent translocation of several lysosomal membrane proteins, including LAMP2, to the cytosol was found. LAMP2 was present in small vesicles with the N-terminal protein chain facing the lumen of the vesicle. We conclude that lysophagic clearance of damaged lysosomes results in generation of lysosomal membrane protein complexes, which constitute small membrane enclosed units, possibly for recycling of lysosomal membrane proteins. These lysosomal membrane complexes enable an efficient regeneration of lysosomes to regain cell functionality.
Asunto(s)
Apoptosis/fisiología , Homeostasis/fisiología , Membranas Intracelulares/metabolismo , Proteínas de Membrana de los Lisosomas/metabolismo , Lisosomas/metabolismo , Autofagia/fisiología , Diferenciación Celular/fisiología , Permeabilidad de la Membrana Celular/fisiología , Citosol/metabolismo , Humanos , Membranas Intracelulares/fisiología , Transducción de Señal/fisiologíaRESUMEN
The phylum Apicomplexa includes a number of significant human pathogens like Toxoplasma gondii and Plasmodium species. These obligate intracellular parasites possess a membranous structure, the inner membrane complex (IMC), composed of flattened vesicles apposed to the plasma membrane. Numerous proteins associated with the IMC are anchored via a lipid post-translational modification termed palmitoylation. This acylation is catalysed by multi-membrane spanning protein S-acyl-transferases (PATs) containing a catalytic Asp-His-His-Cys (DHHC) motif, commonly referred to as DHHCs. Contrasting the redundancy observed in other organisms, several PATs are essential for T. gondii tachyzoite survival; 2 of them, TgDHHC2 and TgDHHC14 being IMC-resident. Disruption of either of these TgDHHCs results in a rapid collapse of the IMC in the developing daughter cells leading to dramatic morphological defects of the parasites while the impact on the other organelles is limited to their localisation but not to their biogenesis. The acyl-transferase activity of TgDHHC2 and TgDHHC14 is involved sequentially in the formation of the sub-compartments of the IMC. Investigation of proteins known to be palmitoylated and localised to these sub-compartments identified TgISP1/3 as well as TgIAP1/2 to lose their membrane association revealing them as likely substrates of TgDHHC2, while these proteins are not impacted by TgDHHC14 depletion.
Asunto(s)
Aciltransferasas/metabolismo , Membranas Intracelulares/fisiología , Lipoilación/genética , Biogénesis de Organelos , Toxoplasma/enzimología , Toxoplasma/fisiología , Acilación , Aciltransferasas/clasificación , Aciltransferasas/genética , Lipoilación/fisiología , Procesamiento Proteico-Postraduccional , Toxoplasma/genéticaRESUMEN
Regulated transport through the secretory pathway is essential for embryonic development and homeostasis. Disruptions in this process impact cell fate, differentiation and survival, often resulting in abnormalities in morphogenesis and in disease. Several congenital malformations are caused by mutations in genes coding for proteins that regulate cargo protein transport in the secretory pathway. The severity of mutant phenotypes and the unclear aetiology of transport protein-associated pathologies have motivated research on the regulation and mechanisms through which these proteins contribute to morphogenesis. This review focuses on the role of the p24/transmembrane emp24 domain (TMED) family of cargo receptors in development and disease.
Asunto(s)
Proteínas de Transporte Vesicular/metabolismo , Proteínas de Transporte Vesicular/fisiología , Animales , Proteínas Portadoras/metabolismo , Humanos , Membranas Intracelulares/metabolismo , Membranas Intracelulares/fisiología , Proteínas de la Membrana/genética , Transporte de Proteínas/genética , Transporte de Proteínas/fisiología , Vesículas Transportadoras/metabolismo , Vesículas Transportadoras/fisiología , Proteínas de Transporte Vesicular/genéticaRESUMEN
Membrane fusion at each organelle requires conserved proteins: Rab-GTPases, effector tethering complexes, Sec1/Munc18 (SM)-family SNARE chaperones, SNAREs of the R, Qa, Qb, and Qc families, and the Sec17/α-SNAP and ATP-dependent Sec18/NSF SNARE chaperone system. The basis of organelle-specific fusion, which is essential for accurate protein compartmentation, has been elusive. Rab family GTPases, SM proteins, and R- and Q-SNAREs may contribute to this specificity. We now report that the fusion supported by SNAREs alone is both inefficient and promiscuous with respect to organelle identity and to stimulation by SM family proteins or complexes. SNARE-only fusion is abolished by the disassembly chaperones Sec17 and Sec18. Efficient fusion in the presence of Sec17 and Sec18 requires a tripartite match between the organellar identities of the R-SNARE, the Q-SNAREs, and the SM protein or complex. The functions of Sec17 and Sec18 are not simply negative regulation; they stimulate fusion with either vacuolar SNAREs and their SM protein complex HOPS or endoplasmic reticulum/cis-Golgi SNAREs and their SM protein Sly1. The fusion complex of each organelle is assembled from its own functionally matching pieces to engage Sec17/Sec18 for fusion stimulation rather than inhibition.
Asunto(s)
Adenosina Trifosfatasas/fisiología , Membranas Intracelulares/fisiología , Fusión de Membrana/fisiología , Chaperonas Moleculares/fisiología , Proteínas Munc18/metabolismo , Orgánulos/metabolismo , Proteínas SNARE/metabolismo , Proteínas de Saccharomyces cerevisiae/fisiología , Saccharomyces cerevisiae/metabolismo , Proteínas Solubles de Unión al Factor Sensible a la N-Etilmaleimida/fisiología , Proteínas de Transporte Vesicular/fisiología , Retículo Endoplásmico/metabolismo , Retículo Endoplásmico/ultraestructura , Aparato de Golgi/metabolismo , Aparato de Golgi/ultraestructura , Lisosomas/metabolismo , Lisosomas/ultraestructura , Complejos Multiproteicos , Especificidad de Órganos , Orgánulos/ultraestructura , Proteolípidos/metabolismo , Proteínas Recombinantes/metabolismo , Vacuolas/metabolismo , Vacuolas/ultraestructuraRESUMEN
In contrast to the plasma membrane, the vacuole membrane has not yet been associated with electrical excitation of plants. Here, we show that mesophyll vacuoles from Arabidopsis sense and control the membrane potential essentially via the K+-permeable TPC1 and TPK channels. Electrical stimuli elicit transient depolarization of the vacuole membrane that can last for seconds. Electrical excitability is suppressed by increased vacuolar Ca2+ levels. In comparison to wild type, vacuoles from the fou2 mutant, harboring TPC1 channels insensitive to luminal Ca2+, can be excited fully by even weak electrical stimuli. The TPC1-loss-of-function mutant tpc1-2 does not respond to electrical stimulation at all, and the loss of TPK1/TPK3-mediated K+ transport affects the duration of TPC1-dependent membrane depolarization. In combination with mathematical modeling, these results show that the vacuolar K+-conducting TPC1 and TPK1/TPK3 channels act in concert to provide for Ca2+- and voltage-induced electrical excitability to the central organelle of plant cells.
Asunto(s)
Proteínas de Arabidopsis/metabolismo , Arabidopsis/fisiología , Canales de Calcio/metabolismo , Potenciales de la Membrana/fisiología , Vacuolas/fisiología , Proteínas de Arabidopsis/genética , Canales de Calcio/genética , Señalización del Calcio/fisiología , Membranas Intracelulares/fisiología , Mutación con Pérdida de Función , Células del Mesófilo/citología , Células del Mesófilo/fisiología , Plantas Modificadas Genéticamente , Potasio/metabolismo , Canales de Potasio/metabolismo , Canales de Potasio de Dominio Poro en Tándem/metabolismoRESUMEN
Glycine receptors (GlyRs) are members of the pentameric ligand-gated ionic channel family (pLGICs) and mediate fast inhibitory neurotransmission in the brain stem and spinal cord. The function of GlyRs can be modulated by positive allosteric modulators (PAMs). So far, it is largely accepted that both the extracellular (ECD) and transmembrane (TMD) domains constitute the primary target for many of these PAMs. On the other hand, the contribution of the intracellular domain (ICD) to the PAM effects on GlyRs remains poorly understood. To gain insight about the role of the ICD in the pharmacology of GlyRs, we examined the contribution of each domain using a chimeric receptor. Two chimeras were generated, one consisting of the ECD of the prokaryotic homologue Gloeobacter violaceus ligand-gated ion channel (GLIC) fused to the TMD of the human α1GlyR lacking the ICD (Lily) and a second with the ICD (Lily-ICD). The sensitivity to PAMs of both chimeric receptors was studied using electrophysiological techniques. The Lily receptor showed a significant decrease in the sensitivity to four recognized PAMs. Remarkably, the incorporation of the ICD into the Lily background was sufficient to restore the wild-type α1GlyR sensitivity to these PAMs. Based on these data, we can suggest that the ICD is necessary to form a pLGIC having full sensitivity to positive allosteric modulators.
Asunto(s)
Regulación Alostérica/fisiología , Receptores de Glicina/fisiología , Regulación Alostérica/efectos de los fármacos , Células Cultivadas , Depresores del Sistema Nervioso Central/farmacología , Quimera , Cianobacterias , Etanol/farmacología , Espacio Extracelular/fisiología , Humanos , Concentración de Iones de Hidrógeno , Membranas Intracelulares/fisiología , Isoflurano/farmacología , Canales Iónicos Activados por Ligandos/fisiología , Potenciales de la Membrana/efectos de los fármacosRESUMEN
Macrophages rely on phagosomal acidity to destroy engulfed microorganisms. To survive this hostile response, opportunistic fungi such as Candida albicans developed strategies to evade the acidic environment. C. albicans is polymorphic and able to convert from yeast to hyphae, and this transition is required to subvert the microbicidal activity of the phagosome. However, the phagosomal lumen, which is acidic and nutrient deprived, is believed to inhibit the yeast-to-hypha transition. To account for this apparent paradox, it was recently proposed that C. albicans produces ammonia that alkalinizes the phagosome, thus facilitating yeast-to-hypha transition. We reexamined the mechanism underlying phagosomal alkalinization by applying dual-wavelength ratiometric pH measurements. The phagosomal membrane was found to be highly permeable to ammonia, which is therefore unlikely to account for the pH elevation. Instead, we find that yeast-to-hypha transition begins within acidic phagosomes and that alkalinization is a consequence of proton leakage induced by excessive membrane distension caused by the expanding hypha.IMPORTANCEC. albicans is the most common cause of nosocomial fungal infection, and over 3 million people acquire life-threatening invasive fungal infections every year. Even if antifungal drugs exist, almost half of these patients will die. Despite this, fungi remain underestimated as pathogens. Our study uses quantitative biophysical approaches to demonstrate that yeast-to-hypha transition occurs within the nutrient-deprived, acidic phagosome and that alkalinization is a consequence, as opposed to the cause, of hyphal growth.
Asunto(s)
Candida albicans/crecimiento & desarrollo , Membranas Intracelulares/fisiología , Fagosomas/química , Fagosomas/microbiología , Animales , Concentración de Iones de Hidrógeno , Hifa/crecimiento & desarrollo , Ratones , Permeabilidad , Fagosomas/fisiología , Células RAW 264.7RESUMEN
PIKfyve, an evolutionarily conserved kinase synthesizing PtdIns5P and PtdIns(3,5)P2, is crucial for mammalian cell proliferation and viability. Accordingly, PIKfyve inhibitors are now in clinical trials as anti-cancer drugs. Among those, apilimod is the most promising, yet its potency to inhibit PIKfyve and affect endomembrane homeostasis is only partially characterized. We demonstrate here for the first time that apilimod powerfully inhibited in vitro synthesis of PtdIns5P along with that of PtdIns(3,5)P2. HPLC-based resolution of intracellular phosphoinositides (PIs) revealed that apilimod triggered a marked reduction of both lipids in the context of intact cells. Notably, there was also a profound rise in PtdIns3P resulting from arrested PtdIns3P consumption for PtdIns(3,5)P2 synthesis. As typical for PIKfyve inhibition and the concomitant PtdIns(3,5)P2 reduction, apilimod induced the appearance of dilated endomembrane structures in the form of large translucent cytoplasmic vacuoles. Remarkably, bafilomycin A1 (BafA1) fully reversed the aberrant cell phenotype back to normal and completely precluded the appearance of cytoplasmic vacuoles when added prior to apilimod. Inspection of the PI profiles ruled out restoration of the reduced PtdIns(3,5)P2 pool as a molecular mechanism underlying BafA1 rescue. Rather, we found that BafA1 markedly attenuated the PtdIns3P elevation under PIKfyve inhibition. This was accompanied by profoundly decreased endosomal recruitment of fusogenic EEA1. Together, our data demonstrate that apilimod inhibits not only PtdIns(3,5)P2 but also PtdIns5P synthesis and that the cytoplasmic vacuolization triggered by the inhibitor is precluded or reversed by BafA1 through a mechanism associated, in part, with reduction in both PtdIns3P levels and EEA1 membrane recruitment.
Asunto(s)
Antineoplásicos/farmacología , Endosomas/efectos de los fármacos , Membranas Intracelulares/efectos de los fármacos , Morfolinas/farmacología , Fosfatidilinositol 3-Quinasas/metabolismo , Fosfatos de Fosfatidilinositol/metabolismo , Triazinas/farmacología , Animales , Células COS , Chlorocebus aethiops , Citoplasma/efectos de los fármacos , Citoplasma/patología , Citoplasma/fisiología , Endosomas/patología , Endosomas/fisiología , Inhibidores Enzimáticos/farmacología , Células HEK293 , Humanos , Hidrazonas , Membranas Intracelulares/patología , Membranas Intracelulares/fisiología , Macrólidos/farmacología , PirimidinasRESUMEN
Lysosomes are highly dynamic organelles that can move rapidly throughout the cell. They distribute in a rather immobile pool located around the microtubule-organizing center in a "cloud," and a highly dynamic pool in the cell periphery. Their spatiotemporal characteristics allow them to carry out multiple biological functions, such as cargo degradation, antigen presentation and plasma membrane repair. Therefore, it is not surprising that lysosomal dysfunction underlies various diseases, including cancer, neurodegenerative and autoimmune diseases. In most of these biological events, the involvement of lysosomes is dependent on their ability to move throughout the cytoplasm, to find and fuse to the correct compartments to receive and deliver substrates for further handling. These dynamics are orchestrated by motor proteins moving along cytoskeletal components. The complexity of the mechanisms responsible for controlling lysosomal transport has recently been appreciated and has yielded novel insights into interorganellar communication, as well as lipid-protein interplay. In this review, we discuss the current understanding of the mechanisms of lysosomal transport and the molecular machineries that control this mobility.
Asunto(s)
Movimiento Celular/fisiología , Endocitosis/fisiología , Lisosomas/fisiología , Transporte Biológico , Dineínas/metabolismo , Membranas Intracelulares/metabolismo , Membranas Intracelulares/fisiología , Cinesinas/metabolismo , Lisosomas/metabolismo , Modelos Biológicos , Miosinas/metabolismo , Fosfatidilinositoles/metabolismo , Análisis Espacio-TemporalRESUMEN
Cryptococcus neoformans is a fungal pathogen with worldwide distribution. C. neoformans resides within mature phagolysosomes where it often evades killing and replicates. C. neoformans induces phagolysosomal membrane permeabilization (PMP), but the mechanism for this phenomenon and its consequences for macrophage viability are unknown. In this study, we used flow cytometry methodology in combination with cell viability markers and LysoTracker to measure PMP in J774.16 and murine bone marrow-derived macrophages infected with C. neoformans Our results showed that cells manifesting PMP were positive for apoptotic markers, indicating an association between PMP and apoptosis. We investigated the role of phospholipase B1 in C. neoformans induction of PMP. Macrophages infected with a C. neoformans Δplb1 mutant had reduced PMP compared with those infected with wild-type and phospholipase B1-complemented strains, suggesting a mechanism of action for this virulence factor. Capsular enlargement inside macrophages was identified as an additional likely mechanism for phagolysosomal membrane damage. Macrophages undergoing apoptosis did not maintain an acidic phagolysosomal pH. Induction of PMP with ciprofloxacin enhanced macrophages to trigger lytic exocytosis whereas nonlytic exocytosis was common in those without PMP. Our results suggest that modulation of PMP is a critical event in determining the outcome of C. neoformans-macrophage interaction.